𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prospects for pluripotent stem cell therapies: Into the clinic and back to the bench

✍ Scribed by Laura Grabel

Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
84 KB
Volume
113
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Pluripotent stem cells, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, both hold great promise for the understanding and treatment of disease. They can be used for drug testing, as in vitro models for human disease progression, and for transplantation therapies. Research in this area has been influenced by the ever‐changing political landscape, particularly in the United States. In this review, we discuss the prospects for clinical application using pluripotent cells, focusing on an evaluation of iPS cell potential, the continuing concern of tumor formation, and a summary of in vitro differentiation protocols and animal models used. We also describe the current clinical trials underway in the United States, as well as the ups and downs of funding for ES cell work. J. Cell. Biochem. 113: 381–387, 2012. © 2011 Wiley Periodicals, Inc.

📜 SIMILAR VOLUMES

Taking stock and planning for the next d
Taking stock and planning for the next decade: Realistic prospects for stem cell therapies for the nervous system
✍ Evan Y. Snyder; George Q. Daley; Margaret Goodell 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

## Abstract In thinking about the practical application of stem cell biology to clinical situations—particularly for the central nervous system (CNS)—it is instructive to remember that the neural stem cell (NSC) field—as a prototype for somatic stem cells in general—emerged as the unanticipated byp

Are induced pluripotent stem cells the f
Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?
✍ Ryan P.F. Salewski; Eftekhar Eftekharpour; Michael G. Fehlings 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

## Abstract Despite advances in medical and surgical care, current clinical therapies for spinal cord injury (SCI) are limited. During the last two decades, the search for new therapies has been revolutionized by the discovery of stem cells, inspiring scientists and clinicians to search for stem ce

Risk of cerebral metastases and neurolog
Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer : Clinical implications for the subsequent management of the brain
✍ Allen M. Chen; Thierry M. Jahan; David M. Jablons; Joaquin Garcia; David A. Lars 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract ## BACKGROUND. The incidence and pattern of brain metastases was analyzed among patients who achieved a pathological complete response (pCR) after neoadjuvant chemotherapy or chemoradiotherapy for locally advanced nonsmall‐cell lung cancer (NSCLC). ## METHODS. Between 1990 and 2004,